Auddia Inc. (NASDAQ: AUUD) today highlighted Influence Healthcare, a healthtech company leveraging artificial intelligence and vertical integration to enable surgeons to lead value-based care (VBC) in high-spend specialties. The announcement comes as Auddia prepares to file its Form S-4 with the Securities and Exchange Commission later this week, a key step in the merger process that will combine Auddia with Thramann Holdings, LLC, the parent of Influence Healthcare, LT350, and Voyex.
Influence Healthcare is designed as a structural alternative to hospital employment and private-equity rollups, aiming to restore physician leadership and reduce administrative burden. The platform organizes surgeons into vertically integrated Value Based Enterprises (VBEs) that contract for bundled case-rate payments in spine, total joints, and other high-cost specialties. These VBEs are supported by advanced AI workflows that automate documentation, coding, episode validation, care-pathway coordination, staffing, supply chain, and logistics, allowing surgeons to focus on clinical care.
“Healthcare is about a physician and patient entering into a relationship to optimize delivery of the highest quality care. Only the physician has the knowledge, relationship with the patient, and clinical authority to make the many real-time decisions required to deliver the highest quality care at the lowest possible price,” said Jeff Thramann, M.D., CEO of Auddia and Founder of Influence Healthcare. “Influence Healthcare is aimed at leveraging AI to minimize administrative noise so that physicians and all the other healthcare professionals with hands on patients are empowered to deliver the highest value care.”
The model is built on the premise that physicians deliver value and should lead the system. Influence Healthcare creates surgeon-led enterprises where surgeons retain governance authority, episode-based economics flow to clinicians, and facilities participate through aligned partnerships rather than ownership. Post-merger, Influence Healthcare will leverage the shared AI services of McCarthy Finney to deploy agentic-AI workflows that automate clinical documentation, coding and billing preparation, episode-of-care validation, prior-authorization workflows, care-pathway adherence monitoring, and communication across the episode.
“AI should not replace physicians, it should replace the administrative friction that prevents physicians from practicing at the top of their license,” Dr. Thramann said. “Our platform gives surgeons the environment they need to deliver a more predictable, coordinated, efficient, and compassionate episode of care.”
The company’s initial focus is on spine and total joint surgery, with plans to expand to additional specialties and markets through physician-led VBEs. Influence Healthcare’s model aims to deliver lower total cost of care, improved outcomes, reduced administrative overhead, predictable economics for payers and employers, and restored autonomy for surgeons. For more information, visit www.influencehealthcare.com.
The merger, announced on February 17, 2026, will result in Auddia changing its name to McCarthy Finney and trading under the ticker MCFN. McCarthy Finney will operate as an AI holding company delivering AI and Web3 services to its portfolio companies: LT350, Influence Healthcare, Voyex, and Auddia. The S-4 filing is expected later this week, marking a significant milestone in the merger process.
